Início › Câncer de Bexiga Não Invasivo Muscular › Nova York

Ensaios clínicos de Câncer de Bexiga Não Invasivo Muscular em Nova York

16 estudos para Câncer de Bexiga Não Invasivo Muscular estão buscando participantes em locais em Nova York.

Cidades em Nova York

Texto oficial do estudo (Inglês)

A Trial of Durvalumab (MEDI4736) Plus Monalizumab in Non-Muscle-Invasive Bladder Cancer

Icahn School of Medicine at Mount Sinai, New York
Weill Cornell Medical Center, New York

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 5 de out. de 2026 · NCT06503614

Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy

Roswell Park Cancer Institute, Buffalo
Memorial Sloan Kettering Commack, Commack
Memorial Sloan Kettering Westchester, Harrison
e mais 3

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT07000084

A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)

Laura and Isaac Perlmutter Cancer Center at NYU Langone Health ( Site 0111), New York

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT06833073

Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer

Icahn School of Medicine at Mount Sinai (ISMMS) - Mount Sinai Queens - Infusion Center, Astoria
NYU Langone Health, New York
Memorial Sloan Kettering Cancer Center - Sidney Kimmel Center for Prostate and Urologic Cancers, New York
e mais 3

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 29 de set. de 2026 · NCT06995677

A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer

Associated Medical Professionals, Syracuse

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT06919965

A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer

MSK Commack, Commack
MSK Westchester, Harrison
Memorial Sloan Kettering Cancer Center - David H. Koch Center for Cancer Care (74th Street)., New York
e mais 9

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT07206225

A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States

SUNY Upstate Med Univ, Syracuse

RecrutandoEstudo observacional

Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT07309445

A Cruciferous Vegetable Eating Program for the Reduction of Cancer Recurrence and Progression in Patients With Non-muscle Invasive Bladder Cancer

Roswell Park Comprehensive Cancer Center, Buffalo

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 17 de set. de 2026 · NCT06733363

Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer

Laura & Isaac Perlmutter Cancer Center - NYU Langone Health, New York
University of Rochester, Department of Urology, Rochester
Associated Medical Professionals of NY, PLLC, Syracuse
e mais 1

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 24 de ago. de 2026 · NCT05951179

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

New York University (NYU), New York
Weill Cornell Medicine, New York
Icahn School of Medicine at Mount Sinai, New York
e mais 4

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 20 de ago. de 2026 · NCT05614739

A Study Comparing Standard Treatments in People With Non-Muscle Invasive Bladder Cancer (NMIBC)

Memorial Sloan Kettering Suffolk - Commack (Consent Only), Commack
Memorial Sloan Kettering Westchester (Consent Only), East White Plains
Columbia University (Data Collection Only), New York
e mais 2

RecrutandoFase 3

Idades 21 e acima · Todos os sexos · Atualizado em 20 de ago. de 2026 · NCT06929286

Study of 2141-V11 in People With Non-muscle Invasive Bladder Cancer That Did Not Respond to Standard Treatment

Memorial Sloan Kettering Commack (Limited Protocol Activities), Commack
Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
e mais 1

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 14 de ago. de 2026 · NCT05126472

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

Albany Medical College, Albany
Roswell Park Cancer Institute, Buffalo
Mount Sinai Medical Center, New Haven
e mais 1

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 7 de ago. de 2026 · NCT04752722

ResQ133A-NMIBC: Intravesical Recombinant Mycobacterium (rMBCG) in Participants With NMIBC Eligible to Receive Intravesical Tice BCG

SUNY Upstate Medical University, Syracuse

RecrutandoFase 1/2

Idades de 18 a 85 · Todos os sexos · Atualizado em 27 de mar. de 2026 · NCT06800963

Blue Light Cystoscopy With Cysview® Registry

NYU Langone's Perlmutter Cancer Center, New York

RecrutandoEstudo observacional

Idades 18 e acima · Todos os sexos · Atualizado em 18 de dez. de 2025 · NCT02660645

Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") Patients

Site 02-015 - Associated Medical Professionals of New York, Syracuse

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 24 de nov. de 2025 · NCT03945162

Fonte: ClinicalTrials.gov, dados obtidos em 6 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.